Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 066695/0664 | |
| Pages: | 9 |
| | Recorded: | 02/28/2024 | | |
Attorney Dkt #: | 2276884 PAT 3 |
Conveyance: | SECOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT |
|
Total properties:
2
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
18034411
|
Filing Dt:
|
04/28/2023
|
Publication #:
|
|
Pub Dt:
|
12/14/2023
| | | | |
Title:
|
RIFAXIMIN LIQUID FORMULATIONS FOR USE IN THE TREATMENT OF SICKLE CELL DISEASE
|
|
|
Patent #:
|
|
Issue Dt:
|
12/05/2023
|
Application #:
|
18193144
|
Filing Dt:
|
03/30/2023
|
Publication #:
|
|
Pub Dt:
|
10/26/2023
| | | | |
Title:
|
ULTRA-PURE AGONISTS OF GUANYLATE CYCLASE C, METHOD OF MAKING AND USING SAME
|
|
Assignee
|
|
|
240 GREENWICH STREET |
NEW YORK, NEW YORK 10286 |
|
Correspondence name and address
|
|
STEWART WALSH
|
|
1025 CONNECTICUT AVE NW, SUITE 712
|
|
COGENCY GLOBAL INC.
|
|
WASHINGTON, DC 20036
|
Search Results as of:
05/10/2024 05:18 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|